ESPR vs TWLO · rev $332.3M vs P/E 1087, rev $2.91B
Esperion Therapeutics Inc (ESPR) versus Twilio Inc (TWLO) — a side-by-side from cached financials, not a winner call.
Esperion Therapeutics Inc (ESPR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Twilio Inc (TWLO) is a software - infrastructure company listed on US.
Latest reported ESPR revenue for 2024-12-31 was $332.3M. Net income was -$51.7M. Revenue was up 185.7% from 2023-12-31 to 2024-12-31. ESPR currently screens at market cap $816.9M.
Latest reported TWLO revenue for 2026-06-30 was $2.91B. Net income was $1.16B. TWLO currently screens at market cap $16.67B and trailing P/E 1086.7.
ESPR currently screens at market cap $816.9M. TWLO currently screens at market cap $16.67B and trailing P/E 1086.7.
Not investment advice. Open the ESPR and TWLO stock pages for the full models.
Not investment advice.